Sider:
Anbefales:
-
Seneste indlæg
- PodCast med Fonagy og Salkovskis: Wake up to the Unconscious
- Bog: Kognitiv terapi – nyeste udvikling
- Bog: anerkendt selvhjælpsbog til OCD-ramte udgivet på dansk
- Radioprogram: The Lobotomists. Om det hvide snit.
- Mishandling af børn medfører langvarig risiko for depression og dårlig respons til behandling
- Mobil applikationer til behandling af PTSD
- Socialpsykologen Hegarty om psykoanalyse, Rorschach og seksualitet
- Rapport: Udkast til behandlingsguideline om Selvskade og Cutting
- Ny åndedrætsterapi reducerer panik og angst ved at vende hyperventilering
- Adfærdsmæssige problemer og kortisol: et paradoks er måske løst
- Anti-mobbe program reducerer ondsindet sladder i skolegården
- Fleksibelt program til behandling af angstlidelser i den primære sundhedssektor
- Interview med Joseph LeDoux
- Er der forskel på kvinders og mænds hjerner?
- Farvel til ideen om at kreativ tænkning findes i højre side af hjernen
Anbefales:
national institute of mental health-arkiv
-
Ketamine treatment for depression?
Udgivet den 23. august 2006 | Ingen kommentarerAccording to a National Institute of Mental Health press release on 7 August 2006, a study of 17 patients led by Dr Carlos Zarate Jr. of the NIMH showed that ketamine significantly improved treatment-resistant major depression within two hours of injection. The improvement lasted up to one week after the single dose. The patients in the study were previously treatment resistant, having tried an average of six other treatments that failed. The importance of these findings was articulated by NIMH director Dr Thomas Insel: "This is the first report of any medication or other treatment that results in such a pronounced, rapid, prolonged response." The researchers apparently attribute the effect to ketamine being an NMDA receptor antagonist. -
Double-Blind Treatment With Oral Morphine in Treatment-Resistant Obsessive-Compulsive Disorder
Udgivet den 9. april 2005 | Ingen kommentarerFor people with obsessive-compulsive disorder (OCD) who have not been helped by standard drug treatments, a weekly dose of oral morphine may ease their symptoms, according to a small pilot study. -
Medtronic Receives Humanitarian Use Device Designation for Treatment of OCD
Udgivet den 29. marts 2005 | Ingen kommentarerLeader in Brain Stimulation Therapy Seeks to Help Patients Suffering from Debilitating Psychiatric Conditions.



